Molecular Technologist - Part Time 1 1

Charles River; Kaarst; Vor Ort; EUR 40.000 - 55.000; Vollzeit

Zusammenfassung

A leading contract research organization in Kaarst is seeking a dedicated individual for a microbiology laboratory role. Responsibilities include processing microbial samples and ensuring compliance with regulations. A vocational education in Biology or similar is preferred, along with proficiency in German and English. This position offers a chance to impact health globally while building a fulfilling career.

Qualifikationen

• No prior work experience required.
• Sequencing / MALDI experience preferred.
• Knowledge about Quality Management preferred.

Aufgaben

• Processing and handling of microbial customer samples in the microbiology laboratory.
• Ensuring compliance with regulatory requirements and GMP compliance.

Kenntnisse

B2 written and spoken German

B1/B2 written and spoken English

Ausbildung

Vocational Education in Biology or related topics

Bachelor’s degree or higher

Jobbeschreibung

Overview

For 75 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

Responsibilities

• Processing and handling of microbial customer samples in the microbiology laboratory using the various technology platforms and ensuring compliance with regulatory requirements and GMP compliance.

Qualifications

• Vocational Education in Biology or related topics. Bachelor’s degree or higher also accepted.
• written and spoken German (B2 or higher)
• written and spoken English (B1 / B2 level)

Experience

• No prior work experience required.
• Sequencing / MALDIexperience preferred
• Knowledge about Quality Management preferred

About Microbial Solutions

Our Microbial Solutions business group has a comprehensive portfolio of endotoxin testing, microbial detection and microbial identification products and services is unlike any other, and has been purposefully designed to meet the complex and ever-changing needs of the industry. We help clients to ensure product safety and quality with easy-to-use yet robust testing solutions that satisfy regulatory requirements, support critical decision making and improve operational efficiencies.

About Charles River

Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 20,000 employees within 110 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.